Presenting Author
VeriSIMlife Inc.
Dr. Khotimchenko is the Principal DMPK Scientist at VeriSIM Life. Dr. Khotimchenko has a strong experience in developing an AI-driven biosimulation platform that enables the pharmaceutical industry with the technology to accelerate and improve outcomes in drug development to advance human health. Dr. Khotimchenko leads research and scientific efforts to make BIOiSIM the most accurate predictor of PK/PD/DDI profiles of xenobiotics. He has almost 20 years experience in experimental pharmacology and drug development studies with the main areas of interests including environmental pharmacology, neuropharmacology and discovery of pharmaceutical compounds with antitumor activity. He and his team had developed active compounds preventing exposure to toxic metal ions and accelerating their removal from the body compartment with low risk of toxicity. Latest research studies were executed with the use of in silico methods with implementation of AI-algorithm helping to model drug PK parameters and predict drug absorption, distribution, and elimination in animal species as well as in humans.